On January 27, 2017, Varian Medical Systems, Inc. (“Varian”) entered into several agreements with Varex Imaging Corporation (“Varex”) in connection with the separation of Varian’s imaging components business (the “Separation”) through the distribution of 100% of the outstanding common stock, par value $0.01 per share, of Varex to Varian’s stockholders of record as of the close of business on January 20, 2017 (the “Distribution”). The company announced the appointment of David J. Illingworth as chair of Ethics and Compliance Committee, Regina E. Dugan and Timothy E. Guertin as members of Ethics and Compliance Committee. The company announced the appointment of Mark R. Laret as chair of Nominating and Corporate Governance Committee, Susan L. Bostrom, Regina E. Dugan and Timothy E. Guertin as members of Nominating and Corporate Governance Committee. R. Andrew Eckert as chair of Executive Commitee and Mark R. Laret as member of Executive Committee of the company. Effective as of the completion of the Separation and Distribution, Magnus A. Momsen was appointed Varian’s Senior Vice President, Chief Accounting Officer and Corporate Controller and became Varian’s Principal Accounting Officer. Mr. Momsen, 42, joined Varian in September 2010 as Controller, Emerging Businesses, where he was responsible for the financial oversight of the Particle Therapy and Security and Inspection products businesses. From August 2012 to January 2017 Mr. Momsen served as Vice President and Assistant Corporate Controller, responsible for the SEC reporting, technical accounting and Corporate accounting departments.